Table S1, Detailed informative data of all collected samples. Table S2, The whole deregulated GO terms of serous ovarian tumors. Table S3, The whole dysfunctional GO pathways for serous ovarian tu
Table S1. Clinicopathological features of 47Â BC patients and the expression of BCRC-3 and miR-182-5p. Table S2 Detailed information of primers and RNA sequences used in this study. (ZIP 22 kb)
* HPV-39 according to ATCC; ** HPV type was undetermined after DNA sequencing. *** Bold in parenthesis indicates amplification within the gained interval. HPV status and chromosome 3 aberrations in th
